BioRestorative Therapies, Inc.

A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.

BRTX | NDAQ

Overview

Corporate Details

ISIN(s):: US0906556065
LEI:
Country:: United States of America
Address:: 40 MARCUS DRIVE, 11747 MELVILLE
Website:: https://www.biorestorative.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioRestorative Therapies, Inc. is a clinical-stage regenerative medicine company focused on developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. The company's lead clinical program centers on BRTX-100, an investigational single-dose therapy derived from bone marrow mesenchymal stem cells, which is in a Phase 2 trial for treating chronic lumbar disc disease. In addition to addressing chronic pain, BioRestorative is developing a pipeline of brown adipose-derived stem cell therapies for metabolic disorders. The company also has a commercial-facing BioCosmeceutical platform that leverages its secretome and exosome-based biologics for applications in aesthetic medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CALTH. Inc Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.	South Korea	402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Develops and manufactures diagnostic tests for food sensitivity and gut health.	United Kingdom	CNSL
Camp4 Therapeutics Corp Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.	United States of America	CAMP
Camurus Develops long-acting medicines for severe chronic diseases using advanced drug delivery.	Sweden	CAMX
CanBas Co.,Ltd. Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.	Japan	4575
Candel Therapeutics, Inc. Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.	United States of America	CADL
Can-Fite BioPharma Ltd. Clinical-stage biopharma developing oral drugs for cancer, inflammatory, liver & metabolic diseases.	United States of America	CANF
Can-Fite BioPharma Ltd. Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.	Israel	CANF
Cannovum Cannabis AG Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.	Germany	27N0
Canopy Growth Corp Produces diverse cannabis products for medical and recreational markets globally.	United States of America	CGC